Ocugen to Present at Retinal Vascular Disease Drug
MALVERN, Pa., Feb. 17, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a
Globe Newswire17-02-2023, 20:18
American Institutes for Research Expands Effort to 16-03-2023, 00:38